Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinomaRitu Chaudhary, Christine H. Chung, Jude Masannat et al.|Molecular Carcinogenesis|2020Cited by 26
Effects of prexasertib, a CHK1 inhibitor, in the immune microenvironment of head and neck squamous cell carcinoma (HNSCC).Ritu Chaudhary, Christine H. Chung, Robbert J.C. Slebos et al.|Journal of Clinical Oncology|2020Cited by 1